Table 1.

The characteristics of all included women.

	CST-I (N = 102)	CST-II (N = 2)	CST-III (N = 111)	CST-IV-A (N = 40)	CST-IV-B (N = 99)	CST-V (N = 2)	Total (N = 356)	P-value (χ2 test)
									HC	34 (30.09%)	2 (1.77%)	28 (24.78%)	20 (17.70%)	28 (24.78%)	1 (0.88%)	113	0.137
HPV	46 (28.93%)	0 (0.00%)	54 (33.96%)	11 (6.92%)	47 (29.56%)	1 (0.63%)	159
CIN	22 (26.19%)	0 (0.00%)	29 (34.52%)	9 (10.71%)	24 (28.57%)	0 (0.00%)	84
CIN1	13 (27.66%)	0 (0.00%)	17 (36.17%)	5 (10.64%)	12 (25.53%)	0 (0.00%)	47	0.988
CIN2	6 (25.00%)	0 (0.00%)	7 (29.17%)	3 (12.50%)	8 (33.33%)	0 (0.00%)	24
CIN3	3 (23.08%)	0 (0.00%)	5 (38.46%)	1 (7.69%)	4 (30.77%)	0 (0.00%)	13
HPV-S	29 (27.10%)	0 (0.00%)	37 (34.58%)	8 (7.48%)	32 (29.91%)	1 (0.93%)	107	0.9
HPV-M	17 (32.69%)	0 (0.00%)	17 (32.69%)	3 (5.77%)	15 (28.85%)	0 (0.00%)	52